n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, November 14th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Rocky Mountain High Brands, Inc. (RMHB)

SmallCapVoice, Promotion Stock Secrets, SizzlingStockPicks, WallstreetSurfers, Penny Picks, ProTrader, Winston Small Cap, Fortune Stock Alerts, PennyPickAlerts, and Damn Good Penny Picks reported earlier on Rocky Mountain High Brands, Inc. (RMHB), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Rocky Mountain High Brands, Inc. is a consumer goods company with its corporate headquarters in Dallas, Texas. Its specialty is brand development of health conscious, hemp-infused, food and beverage products and naturally high alkaline water. Rocky Mountain High Brands has now launched its naturally high alkaline spring water, Eagle Spirit Spring Water. Rocky Mountain High Brands lists on the OTC Markets Group’s OTCQB.

Rocky Mountain employs a hybrid distribution model. This model takes advantage of distribution contacts and brokers, and direct relationships with wholesalers and retailers to expand strategically into new markets. The Company engages in sales and distribution through online retailers. It presently distributes its products to a variety of retail locations, from grocery to convenience to warehouse stores, throughout the United States.

At present, the Company markets a lineup of four naturally flavored hemp-infused beverages. These are Citrus Energy, Black Tea, Mango Energy and Lemonade. In addition, Rocky Mountain High Brands markets a low-calorie Coconut Lime Energy drink. Moreover, it offers hemp-infused 2 oz. Mango Energy Shots and Mixed Berry Energy Shots.

Rocky Mountain High Brands has launched its strong GPS based geofencing software advertising system in the Los Angeles, California market. Geofencing is the practice of utilizing Global Positioning (GPS) or radio frequency identification (RFID) to define a geographic boundary.

The Company’s geofencing software package underwent development by the Beasley Broadcast Group's (BBGI) Digital Marketing Solutions division. The design of the software package is to interface with mobile devices when a consumer is within proximity of a Rocky Mountain High retailer.

In March of this year, Rocky Mountain High Brands announced that it entered into an agreement with L and H Resort Systems to acquire a former Catskill Mountain resort facility situated on a natural spring. The Company’s plan is to repurpose the resort into a Bottling and Canning Plant for Rocky Mountain High Brands.

Last month, Rocky Mountain High Brands announced that it has retained Mr. Jonathan Miller, Member-in-Charge of the Lexington office of the law firm of Frost Brown Todd LLC, to assist the Company in exploring entry into the hemp-derived CBD (cannabidiol) market. Frost Brown Todd is a full-service law firm. It has over 500 attorneys in eight states (including Texas). It has been instrumental in securing federal and state legislation, which have advanced the growth of the developing industrial hemp and CBD industries, and in helping companies navigate state and federal legal and regulatory issues.

Rocky Mountain High Brands also announced in October that its subsidiary, Rocky Mountain High Water Company, LLC, has a non-gaming vendor registration license with Osage Casinos, the gaming enterprise of the Osage Tribe, to sell its Eagle Spirit Spring Water in their retail establishments. Under the license, Eagle Spirit Spring Water is now selling in this market. Osage Casinos now has seven gaming centers across Osage County. These include Tulsa, Bartlesville, Sand Springs, Ponca City, Skiatook, Hominy and Pawhuska.

Rocky Mountain High Brands, Inc. (RMHB), closed Tuesday's trading session at $0.0135, down 8.16%, on 8,077,490 volume with 153 trades. The average volume for the last 60 days is 4,655,638 and the stock's 52-week low/high is $0.0131/$0.164.

Solis Tek, Inc. (SLTK)

Trading View, Zacks, and MarketWatch reported on Solis Tek, Inc. (SLTK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Solis Tek, Inc. is a vertically integrated technology innovator, developer, manufacturer, and distributor. Its emphasis is on bringing products and solutions to commercial cannabis growers in legal markets across the United States. The OTCQB-listed Company’s focus is on the research, design, development, and manufacturing of advanced and efficient lighting products. Its customers include retail stores, distributors, and commercial growers in the United States and globally. Solis Tek has its corporate headquarters in Carson, California.

The Company provides a wide-ranging line of lighting equipment and accessories to help its customers attain higher yields and maximize quality. Solis Tek product categories include complete systems; digital ballasts, DE Lamps; SE Lamps; CMH Lamps; Reflectors; and accessories.

Solis Tek’s technology encompasses Ignition Control; SenseSmart™, and the industry’s lowest output THD (Total Harmonic Distortion) percent. The Company states that its ballasts offer the industry's only true Ignition Control staggered ignition technology. Solis Tek's sequential lamp ignition technology will ignite lamps one at a time based on load stability.

The Company’s SenseSmart™ will check for eight different factors before attempting to power the lamp. The intention of this is increased user safety. SenseSmart™ checks for open output; high/low temperatures; ignition failure; thermal; end of lamp life; overflow current; over/low voltage; and short circuit.

Solis Tek has its Nutrient Line. This Line utilizes natural ingredients to help growers increase yield, lower costs, and ultimately grow healthier plants. This an aspect of the Company’s overall strategy to provide a broad group of products and services targeted at the commercial cannabis industry.

Terpenez™ is the first product in the Nutrient Line. This product is an organically derived, commercial grade essential oil intensifier blended in the State of California.

The design of it is to naturally increase the terpene profile of the cannabis plant and enhance the aromatic experience associated with gardening. Terpenez™ identifies the plant's terpene profile. It utilizes natural ingredients to boost the terpene levels, accordingly enhancing the plant's innate characteristics.

Solis Tek announced this past summer that controlled third-party independent testing efforts yielded results revealing no heavy metals in Terpenez™. A & L Western Agricultural Laboratories, Inc. conducted the laboratory analysis of Terpenez. The focus of the analysis was to ensure product safety and efficacy. The laboratory analysis determined the level of heavy metals in Terpenez to be below the EPA's (Environmental Protection Agency) detection limit (BDL). A & L Western Agricultural Laboratories is an independent bioanalytical testing and research laboratory. It provides services to the agriculture industry

Recently, Solis Tek announced the availability of its lighting controller that enables commercial growers to harness more control of its garden's lighting environment. The Solis Tek Controller works with up to 300 lights at once. It permits growers to manage multiple lighting cycles, located in different rooms/locations.

Solis Tek, Inc. (SLTK), closed Tuesday's trading session at $1.31, down 5.07%, on 141,291 volume with 173 trades. The average volume for the last 60 days is 68,154 and the stock's 52-week low/high is $0.25/$3.44.

Vitality Biopharma, Inc. (VBIO)

Stock Beast, SmallCap Network, and Promotion Stock Secrets reported previously on Vitality Biopharma, Inc. (VBIO), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Vitality Biopharma, Inc.’s commitment is to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Since 2012, it has developed a unique capability to produce molecules via glycosylation, a form of enzymatic biosynthesis that was originally developed to improve the taste of stevia. The platform is well suited for the discovery of new pharmaceutical products. OTCQB-listed, Vitality Biopharma is based in Los Angeles, California.

Late in 2015, Vitality successfully modified cannabidiol (CBD), which is not psychoactive, and in ongoing work has created a novel class of pharmaceuticals named cannabosides. Cannabosides, upon ingestion, can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits. This is while lessening or avoiding the systemic delivery of THC into the bloodstream.

Vitality Biopharma completed preclinical pharmacokinetics studies with its proprietary THC glycosides to analyze their bioavailability. The Company has confirmed that large concentrations can be delivered orally without significant transit of THC to the brain, enabling their formulation within pharmaceuticals where drug psychoactivity will be lessened or eliminated.

The Company can biosynthesize cannabinoid glycosides (cannabosides) through enzyme biosynthesis. Vitality is one of only a very few groups internationally who know how to produce and work with the enzymes that perform glycosylation. It has been focused on it because the same enzymes are used to modify the taste of stevia (steviol glycosides).

Vitality Biopharma announced earlier this year that it has positive results indicating a new use for its proprietary prodrug cannabinoid delivery platform. Many colon cancer cell types were screened, each with unique combinations of genetic mutations that drive cancerous growth, and including a cell line known to express drug-resistance genes such as PD-L1.

Vitality Biopharma found that cannabidiol (CBD) universally inhibited cell growth at concentrations similar to established chemotherapeutics. It also found that its cannabidiol prodrug was not toxic to the human cells at the concentrations tested, demonstrating the relative safety of its prodrug delivery system.

Vitality Biopharma has obtained positive results demonstrating antimicrobial activity of cannabinoids. It filed for patent protection on the use of cannabinoid compounds for the treatment of microbes. This includes Clostridium difficile and other "superbug" pathogens.

In July, Vitality Biopharma announced positive preclinical efficacy results for its gut-targeted cannabosides in the treatment of colitis. The Company has developed a new class of cannabinoid prodrugs, called cannabosides that upon ingestion can be targeted and limited to the gastrointestinal tract thus avoiding drug psychoactivity and unforeseen side effects. In a preclinical model of inflammatory bowel disease (IBD), cannabosides were able to decrease weight loss, lessen damage to the colon, and noticeably improve gastrointestinal health versus the placebo controls.

Last month, Vitality Biopharma announced the attainment of a biosynthesis breakthrough. The Company has developed a proprietary biosynthesis technology, which can modify cannabinoids to create pharmaceutical prodrugs that have no psychoactivity and that can provide targeted disease treatment. The process involves small molecule glycosylation, where sugar molecules are attached to cannabinoids, creating new compounds called cannabinoid glycosides, or cannabosides.

Vitality Biopharma announced in October the publication of a global PCT patent application that encompasses a new class of cannabinoid pharmaceuticals. The publication of the international patent filing is the first public disclosure of its full content. This includes 79 patent claims and close to 200 individual compounds. Furthermore, Vitality has filed for intellectual property (IP) coverage for methods to treat dysbiosis, gastrointestinal infections, and other digestive disorders employing cannabinoids.

Vitality Biopharma, Inc. (VBIO), closed Tuesday's trading session at $1.81, down 9.05%, on 173,218 volume with 291 trades. The average volume for the last 60 days is 159,809 and the stock's 52-week low/high is $0.78/$4.24.

American Cannabis Company, Inc. (AMMJ)

Promotion Stock Secrets, CFN Media Group, Cannabis Financial Network News, Stock News Now, Wealth Insider Alert, Market Intelligence Central, Wall Street Daily, The Street, Marketbeat, and TheOTCInvestor reported on American Cannabis Company, Inc. (AMMJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Cannabis Company, Inc. is a full-service Business-to-Business (B2B) consulting solutions provider. The OTCQB-listed Company is also a seller of ancillary products to the cannabis industry. American Cannabis provides end-to-end solutions to existing and ambitious participants in the cannabis industry. It supports its clients from concept to creation, commercialization and continuing operations. American Cannabis Company has its head office in Denver, Colorado.

The Company provides total consulting management and products solutions to the regulated cannabis markets. It uses its industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure, and establish operational best practices.

American Cannabis Company has its proprietary product called SoHum Living Soils™. SoHum Living Soils™ is a proprietary "just add water" growing medium. It contains 100 percent natural ingredients. SoHum Living Soils® won the 2017 High Times STASH award for "Best Potting Mix."

SoHum Living Soils™ provides the plant a complete buffet of macro/micro nutrients to achieve genetic optimization of the cannabis plant. In addition, American Cannabis owns The Cultivation Cube™, and The High Density Cultivation System™ - proprietary cultivation products.

Regarding Consulting, American Cannabis provides application support, business planning, site selection, and regulatory compliance, among other services. Pertaining to Management, it provides yield analysis, staffing, business coaching, and staff training and education, and more.

Concerning Products, American Cannabis provides a complete organic grow system, retail solutions (the Satchel™), grow components, and group purchasing discounts for supplies. The Satchel is a child-proof, tamper-proof vessel for dispensaries. The Satchel™ may be utilized by dispensaries to assemble orders and ensure the proper post sale handling of cannabis per each state's legislation.

American Cannabis Company has signed an exclusive distribution agreement with Earth Alive. The agreement allows for the commercialization of Earth Alive's premier cannabis microbial inoculant product - Dr. Marijane. Dr. Marijane is a certified organic root probiotic. It promotes increased vegetative growth, improves the bioavailability of fertilizer programs, and sustains healthy development and structuring of plant roots. Earth Alive is a foremost Canadian clean-technology enterprise. Earth Alive develops and manufactures state-of-the-art microbial technology-based products.

American Cannabis Company, Inc. (AMMJ), closed Tuesday's trading session at $0.74, up 6.47%, on 258,451 volume with 203 trades. The average volume for the last 60 days is 340,980 and the stock's 52-week low/high is $0.35/$1.40.

CytoDyn, Inc. (CYDY)

OTCtipReporter, SeeThruEquity Research, Stock News Now, PennyStockRumors.net, StockOodles, PennyStockScholar, Profitable Trader Authority, and AllPennyStocks reported previously on CytoDyn, Inc. (CYDY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biotechnology company, CytoDyn, Inc. is concentrating on developing subcutaneously delivered humanized cell-specific monoclonal antibodies (mAbs) as entry inhibitors for the treatment and prevention of Human Immunodeficiency Virus (HIV). The Company has one of the leading mAbs under development for HIV infection: PRO 140. This mAb is its novel self-injectable antibody for the treatment of HIV. PRO 140 has finished Phase 2 clinical trials with demonstrated antiviral activity in humans and is now in Phase 3. CytoDyn has its corporate office in Vancouver, Washington.

PRO 140 is a humanized monoclonal antibody directed against CCR5, a molecular portal that HIV uses to enter cells. PRO 140 belongs to a new class of HIV/AIDS therapeutics - viral-entry inhibitors. The intention of these is to protect healthy cells from viral infection. PRO 140 blocks the HIV co-receptor CCR5. Clinical trial results so far indicate that it does not affect the normal function of the cell.

Results from Phase 1/1b and Phase 2a human clinical trials have shown that PRO 140 can considerably lessen viral burden in people infected with HIV. A Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several weeks of interruption from conventional drug therapy. CytoDyn’s goal is to continue to develop PRO 140 as a therapeutic anti-viral agent in persons infected with HIV. In addition, PRO 140 has been designated a "fast track" product candidate by the Food and Drug Administration (FDA).

CytoDyn’s completed Phase 2b treatment substitution trial demonstrated that 98 percent of all patients treated with PRO 140 successfully passed four weeks of monotherapy without virologic failure. The Company said that its research data has expanded the potential clinical indications for PRO 140 to include certain inflammatory diseases, autoimmunity, transplantation, as well as cancer.

Recently, CytoDyn announced that the FDA granted Orphan Drug Designation (ODD) to PRO 140 for the prevention of graft versus host disease (GvHD). Orphan Drug Designation is granted to development-stage drugs that have shown promise in addressing serious medical needs for patients living with rare conditions.

The designation provides CytoDyn with various incentives and benefits. This includes seven years of U.S. market exclusivity for PRO 140 in GvHD, subject to FDA approval for use in this indication.

CytoDyn also announced that in a meeting, which took place October 12, 2017, the FDA confirmed the number and type of evaluable patients required for submission of a Biologics License Application (BLA) for PRO 140 as a combination therapy. The FDA accepted the 40 patients presently enrolled in the Company’s Phase 2b/3 pivotal combination trial as evaluable.

Also, the FDA further agreed that the trial’s Data Monitoring Committee can conduct an interim efficacy analysis of primary endpoint. Furthermore, the FDA confirmed that 50 patients will be required for the completion of this trial. It agreed to allow more flexibility in the enrolment criteria for the remaining 10 patients. Therefore, CytoDyn expects to complete enrolment soon. 

CytoDyn, Inc. (CYDY), closed Tuesday's trading session at $0.63, down 1.56%, on 129,606 volume with 43 trades. The average volume for the last 60 days is 125,076 and the stock's 52-week low/high is $0.4551/$0.84.

Jones Soda Co. (JSDA)

Stock Analyzer, SuperNova Elite, Wealthpire Inc., Investor Update, SmallCapVoice, Actual Gains, PennyStockRumors.net, PricelessPennyStocks, SmarTrend Newsletters, TopStockAnalysts, and Dividend Opportunities reported earlier on Jones Soda Co. (JSDA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Jones Soda Co. is a leader in the premium soda category. It has a reputation for its unique flavors and branding. Jones Soda markets and distributes premium beverages under the Jones® Soda, Jones Zilch®, Jones Stripped™ and Lemoncocco™ brands. Jones Soda sells across North America in glass bottles, cans and on fountain by way of traditional beverage outlets, restaurants, and alternative accounts. Jones Soda is based in Seattle, Washington.

Jones Soda is made with pure cane sugar. The Company’s diverse product line includes pure cane sugar soda, zero-calorie soda, and an all-naturally sweetened sparkling beverage with only 30 calories and 8 grams of sugar. Jones Soda also sells Jones Gear (clothing items) and Jones Candy.

Jones Soda has its natural soda line - Jones Stripped. Natural Jones Soda launched in California during 2013 to meet the growing demand for healthier beverage options and to expand the Jones product portfolio. Jones Stripped is sweetened with a blend of natural sweeteners. These include pure cane sugar, organic agave syrup, and stevia.

7-Eleven, Inc. and Jones Soda have partnered and created 7-Select® brand premium sodas crafted by Jones, the first premium carbonated beverage in the 7-Select private brand lineup. Each 7-Select premium soda is made with natural flavors, lightly sweetened with cane sugar, and ranges from only 180 to 195 calories per 20-ounce bottle. In addition, this brand includes 75 mg. of caffeine in each serving.

Jones Beverages International is a subsidiary of Jones Soda. It has its premium non-carbonated blended beverage brand - Lemoncocco™. This product is flavored with the extracts of Sicilian lemons and a bit of coconut cream. Lemoncocco™ is a natural beverage, lightly sweetened with a little cane sugar. It is 90 calories per 12 ounce serving, and is dairy free and gluten free.

Last week, Jones Soda announced results for Q3 ended September 30, 2017. For Q3 2017, it reported Revenue of $3.6 million, versus the prior year’s Q3 Revenue of $4.1 million. The Company reported a Net Loss for Q3 of 2017 of $211,000 or ($0.01) per share, versus a Net Income of $69,000 or $0.00 per share, for Q3 2016.

Ms. Jennifer L. Cue, Jones Soda’s Chief Executive Officer, said, “While we have had a challenging year due primarily to the loss of our Jones 12-ounce can listing, we are very excited by the growth of two of our newer initiatives, Lemoncocco and our Jones Cane Sugar fountain program. During 2017, we have added over 1,000 new retail doors for Lemoncocco including 2 divisions of Whole Foods as well as Safeway NorCal, Raley’s and the Mariano’s grocery chain in Chicago. Lemoncocco represents the Company’s diversification into lower calorie, natural beverages, to better meet changing consumer beverage trends. Equally exciting, our Fountain revenue grew by 200 percent for the nine month period as we continue to land increasingly larger sized quick service restaurants and accounts.”

Jones Soda Co. (JSDA), closed Tuesday's trading session at $0.435, up 1.16%, on 25,020 volume with 12 trades. The average volume for the last 60 days is 34,629 and the stock's 52-week low/high is $0.30/$0.60.

OWC Pharmaceutical Research Corp. (OWCP)

Promotion Stock Secrets, CFN Media Group, and Cannabis Financial Network News reported earlier on OWC Pharmaceutical Research Corp. (OWCP), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

OWC Pharmaceutical Research Corp. engages in the research and development (R&D) of cannabis-based medical products. The Company provides medical products for the treatment of varied medical conditions and/or diseases. These include multiple myeloma, psoriasis, PTSD, and migraines; as well as delivery systems. One World Cannabis Ltd. is a wholly-owned subsidiary of OWC Pharmaceutical Research. OWC has its head office in Petach Tikva, Israel. The Company lists on the OTC Markets’ OTCQB.

One World Cannabis’ Research Division concentrates on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of diverse medical conditions. Its Consulting Division’s devotion is to helping governments and companies navigate complex international cannabis regulatory frameworks. A medical cannabis R&D business, all of the Company’s research occurs at leading Israeli hospitals and scientific institutions, and are led by globally distinguished investigators.

OWC Pharmaceutical Research has entered into research and collaboration agreements with three of the top research institutions in Israel. These include Sheba Academic Medical Center, one of the foremost academic hospitals in the Middle East.

These agreements serve as the foundation for OWC’s clinical trials. They ensure that all of its studies have been, and will continue to be, based on established research protocols of the U.S. Food and Drug Administration (FDA), Institutional Review Boards, as well as Independent Ethical Committees.

OWC Pharmaceutical Research has completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the tablet is protected. It provides for the ingestion of almost any dosage of medical cannabis with a sublingual delivery mechanism, where the compounds are absorbed directly into the patient's blood via oral epithelial tissue.

OWC Pharmaceutical Research and mediq Innovation Partners (Frankfurt, Germany) have an agreement for the introduction of OWC's active cannabinoid-based topical psoriasis cream to the German market. mediq has comprehensive experience, knowledge, and a successful record of accomplishment in enabling Israel-based companies to penetrate the European markets.

mediq's goals for OWC Pharmaceutical Research will consist of scientific collaboration. Most importantly it will consist of the development of a commercial market for OWC's proprietary, active cannabinoid-based topical psoriasis cream in Germany.

OWC has received the first ever Institutional Review Board (IRB) approval to conduct a safety study for a cannabis-based topical cream with more than 3 percent THC. The Company is actively conducting a safety study (FDA Phase 1 equivalent) in one of the largest academic hospitals in Israel.

In addition, the Company has completed the development of an orally disintegrating tablet, an important new delivery form. Also, OWC’s topical cream for Psoriasis is market ready.

OWC Pharmaceutical Research Corp. (OWCP), closed Tuesday's trading session at $0.35, up 12.12%, on 1,418,866 volume with 324 trades. The average volume for the last 60 days is 982,784 and the stock's 52-week low/high is $0.075/$3.23.

graphic

The QualityStocks
Company Corner

graphic
graphic

RJD Green Inc. (RJDG)

The QualityStocks Daily Newsletter would like to spotlight RJD Green Inc. (RJDG). Today, RJD Green Inc. closed trading at $0.0085, up 23.37%, on 3,499,565 volume with 48 trades. The stock’s average daily volume over the past 60 days is 1,747,162, and its 52-week low/high is $0.0025/$0.029.

RJD Green Inc. (RJDG), a three-division holding company focused on the health care services, environmental, and construction/industrial services segments, today announces the Animal Waste Management Division has completed the operating software platform necessary for computerized management of the patented waste to protein process. This allows RJD Green to move forward with capital procurement efforts to build and operate the first plant. Timing of funding efforts is scheduled post audit approval within the acquisition funding package.

RJD Green Inc. (RJDG) is a holding company with a focus on acquiring and managing assets and companies in three divisions. These initial high-growth enterprise opportunities offer diversity in separate recession resistant markets. The division holdings include:

  • RJD Green Healthcare Services – provides services to reduce cost and enhance management and operational capabilities in the healthcare sector.
  • Earthlinc Environmental Services – provides green environmental services and technologies.
  • Silex Holdings – acquires specialty construction and industrial manufacturing assets.

RJD Green Healthcare Services, through its wholly owned subsidiary IOSOFT Inc., provides proprietary software and IT support for medical billing, healthcare claims adjudication, and electronic payments between healthcare payers and providers. IOSOFT's unique payment technologies and services or software can be integrated with existing systems of healthcare payers such as Blue Cross, Aetna, CIGNA and others. IOSOFT provides targeted offerings for healthcare providers, provider networks, physicians and hospitals, and clearinghouse companies.

Earthlinc Environmental Solutions was formed to bring forward green-applied technologies and offer environmental services with a focus on North America. The division's first acquisition, Animal Waste Management, is launching operations of a patented, fully developed technology for processing waste produced on commercial poultry and hog farms. Development of this technology was supported by the University of Arkansas and the Missouri Department of Natural Resources. This important technology improves the farm's productivity and is competitively priced with the current expense of handling waste removal at these sites.

The company's third division – Silex Holdings Inc. – was formed to acquire and manage high-growth assets and business enterprises in the industrial and construction specialty services sectors. With its first acquisition of Silex Interiors, a manufacturer, distributor and installer of counter tops, cabinets and related kitchen and bath products, the division is poised to expand into major national markets through internal expansion, acquisition and franchising. The company is modeled to operate a minimum of four corporately owned locations with 12 to 18 franchise locations nationwide.

RJD Green seeks to participate as owners, partners or in joint ventures in a wide range of business enterprises. The company's goal of creating a successful, enjoyable business enterprise for its company team and staff, along with its business partners and investors, is paired with the goal of maximizing the business potential of the enterprise by enhancing profits and the quality of the company. Disclaimer

RJD Green Inc. Company Blog

RJD Green Inc. News:

RJD Green, Inc. Updates Progression of Animal Waste Management and 2017 10K Filing

RJD Green Inc. Appoints Director

RJD Green Inc. Subsidiary, IOSOFT, Discusses Contracts Procured and Revenue Expectations

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.47, off by 5.05%, on 59,128 volume with 41 trades. The stock’s average daily volume over the past 60 days is 108,934 and its 52-week low/high is $0.40/$2.75.

ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, today announced that its wholly owned subsidiary ChineseHempOil.com, Inc. launched its OptHemp product line on Amazon.com kicking off a multi-channel campaign geared to both the US and Chinese-American markets during the 9th annual Singles Day Celebration.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

ChineseInvestors.com, Inc. Announces that its Subsidiary ChineseHempOil.com, Inc. Launched its OptHemp Product Line on Amazon for Singles Day 2017

NetworkNewsBreaks – ChineseInvestors.com, Inc.’s (CIIX) Investor Relations Division Generates Substantial Revenues

ChineseInvestors.com, Inc. Announces Board of Directors Appointments

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.0089, up 8.54%, on 945,293 volume with 21 trades. The stock’s average daily volume over the past 60 days is 255,954 and its 52-week low/high is $0.002/$0.03.

AppSwarm, Inc. (OTC: SWRM), a technology company specializing in the accelerated development and publishing of mobile apps, is pleased to announce that the Company has entered into a Letter of Intent for the development of a smartphone based cash and bitcoin mobile wallet with USA Real Estate Holding Co (OTC PINK: USTC). Pursuant to terms of the Agreement, SWRM and USTC will execute a definitive agreement within 45 days from this Letter of Intent.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm, Inc. (SWRM) and USA Real Estate Holding Company (USTC) Sign LOI to Launch Bitcoin Mobile Wallet

AppSwarm and SinglePoint Sign LOI to Conduct a Shared Roll-Out of Mobile Applications Specifically Geared to the Cannabis Industry

AppSwarm and SinglePoint Sign LOI to Launch Cannabis-Focused Applications

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.05609, off by 2.72%, on 1,527,028 volume with 176 trades. The stock’s average daily volume over the past 60 days is 3,063,585, and its 52-week low/high is $0.002/$0.0995.

PotNetwork Holding, Inc. (OTC: POTN) announced today that the Company’s subsidiary, Diamond CBD, is exhibiting at the 6th Annual MJBizCon event. This trade show attracts not only the largest, but the most-qualified buying audience of any cannabis event in America. The MJBizCon Expo is home to over 650 vendors, and expects attendees to exceed 14,000. This semi-annual, all-professional event has earned a reputation of being “the event where deals get done.” Recognized as the fastest-growing trade show in the country across all industries in 2016, more product and service providers in the cannabis industry depend on MJBizCon to deliver results than any other trade event in the industry.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Subsidiary Diamond CBD to Exhibit at the 6th Annual Las Vegas MJBizCon Event

PotNetwork Holding, Inc. Announces Distribution Partnership for Easy Grinder™

PotNetwork CEO, Dr. Richard Goulding Updates Shareholders on PublicWire.com

Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB:PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $1.04, off by 1.89%, on 271,538 volume with 207 trades. The stock’s average daily volume over the past 60 days is 193,816, and its 52-week low/high is $0.4665/$1.54.

Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB:PTOTF), is pleased to advise that it has closed on the previously announced $10M bought deal financing. The financing was with a syndicate of underwriters led by Canaccord Genuity Corp. and increased in size to close at $11.5M in gross proceeds to the company.

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

Patriot One Accelerates Expansion & Development Plans After Closing $11.5M Financing

Patriot One Technologies Inc. Announces Closing of $11.5 Million Bought Deal Offering

Patriot One Technologies Inc. Announces an Increase to the Previously Announced Bought Deal Financing

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.17, off by 8.11%, on 72,290 volume with 20 trades. The stock’s average daily volume over the past 60 days is 83,248 and its 52-week low/high is $0.0711/$0.2419.

Tapinator, Inc. (OTCQB: TAPM), a leading developer and publisher of mobile games on the iOS, Google Play and Amazon Platforms, today announced quarterly financial results and the filing of its quarterly report for the period ended September 30, 2017.  The quarterly report and unaudited financial statements may be found at: http://www.otcmarkets.com/stock/TAPM/filings

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

Tapinator Releases Third Quarter 2017 Results

NetworkNewsWire Announces Publication on New Mobile Gaming Partnership in Profitable Field

Chinese Mobile Gaming Surge Helps Boost U.S. Mobile Gaming Companies

HighCom Global Security, Inc. (HCGS)

The QualityStocks Daily Newsletter would like to spotlight HighCom Global Security, Inc. (HCGS). Today, HighCom Global Security, Inc. closed trading at $0.02, up 27.39%, on 100,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 53,874 and its 52-week low/high is $0.006/$0.10.

HighCom Global Security, Inc. (HCGS) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

BlastGard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

HighCom Global Security, Inc. Blog

HighCom Global Security, Inc. News:

HighCom Global Security Provides Q2, FH 2017 Financial Update

HighCom Global Security Issues Update on Product Technology Advances

HighCom Global Security Introduces New CEO and Board of Directors as Part of Globally Focused Restructuring Plan

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Buzz Stocks
(ALPP) +192.31%

2.

Barchart
(MARK) +29.62%

3.

QualityStocks
(HCGS) +27.39%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251